CHARLES HIGGINS: Open Payments
NPI 1932476199 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 25 payments from 8 companies in 2025. Trend: 2023 $1,020 · 2024 $691 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 13 | $177 |
| Lundbeck LLC | 3 | $59 |
| ABBVIE INC. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Indivior Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: Azstarys, REXULTI, VRAYLAR, TRINTELLIX, SUBLOCADE, Auvelity, CAPLYTA.
Industry payments across LA — which companies pay providers there.
